Patents by Inventor Leif Andersson

Leif Andersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11335059
    Abstract: The present invention relates to a method and an arrangement for providing a 3D model of an environment. The method comprises the step of forming a mesh modelling the environment in three dimensions, said mesh comprising nodes interconnected by edges and having surfaces boarded by the edges, wherein each node is associated to a 3D coordinate in a geographical coordinate system, determining for a plurality of the nodes and/or surfaces and/or edges in the mesh a mesh uncertainty and associating the determined mesh uncertainty to the corresponding node and/or surface and/or edge.
    Type: Grant
    Filed: January 21, 2013
    Date of Patent: May 17, 2022
    Assignee: Maxar International Sweden AB
    Inventors: Folke Isaksson, Johan Bejeryd, Per Carlbom, Johan Borg, Ingmar Andersson, Leif Haglund
  • Patent number: 11286527
    Abstract: The present invention relates to methods for detecting a genetic deletion at the SHOX locus of a horse, where the presence of such a genetic deletion indicates that the horse is a carrier of disease-causing mutation that can lead to skeletal atavism. The invention further provides nucleic acid primers and probes for use in methods for detecting the presence or absence of disease-causing genetic deletion at the SHOX locus of a horse.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: March 29, 2022
    Assignees: CAPILET GENETICS AB, UNIVERSITY OF WASHINGTON
    Inventors: Sofia Mikko, Leif Andersson, Gabriella Lindgren, Carl-Johan Rubin, Bhanu Chowdhary, Terje Raudsepp, Evan E. Eichler, John Huddleston, Maika Malig
  • Publication number: 20220056530
    Abstract: The present invention provides methods for predicting the pattern of locomotion in a horse including the ability of a horse to use different gaits and the ability to trot at a fast speed. The methods comprise determining in a sample of DNA obtained from a horse the presence or absence of at least one genetic marker, wherein said at least one genetic marker is located on horse chromosome 23, said marker being associated with the ability to use different gaits. The invention further provides primers that amplify markers being associated with the ability to use different gaits and hybridization probes to detect markers being associated with the ability to use different gaits and the ability to trot at a fast speed.
    Type: Application
    Filed: November 10, 2021
    Publication date: February 24, 2022
    Applicant: Capilet Genetics AB
    Inventors: Lisa S. Andersson, Leif Andersson, Gabriella Lindgren
  • Publication number: 20190382843
    Abstract: The present invention provides methods for predicting the pattern of locomotion in a horse including the ability of a horse to use different gaits and the ability to trot at a fast speed. The methods comprise determining in a sample of DNA obtained from a horse the presence or absence of at least one genetic marker, wherein said at least one genetic marker is located on horse chromosome 23, said marker being associated with the ability to use different gaits. The invention further provides primers that amplify markers being associated with the ability to use different gaits and hybridization probes to detect markers being associated with the ability to use different gaits and the ability to trot at a fast speed.
    Type: Application
    Filed: June 20, 2019
    Publication date: December 19, 2019
    Applicant: Capilet Genetics AB
    Inventors: Lisa S. Andersson, Leif Andersson, Gabriella Lindgren
  • Patent number: 10378057
    Abstract: The present invention provides methods for predicting the pattern of locomotion in a horse including the ability of a horse to use different gaits and the ability to trot at a fast speed. The methods comprise determining in a sample of DNA obtained from a horse the presence or absence of at least one genetic marker, wherein said at least one genetic marker is located on horse chromosome 23, said marker being associated with the ability to use different gaits. The invention further provides primers that amplify markers being associated with the ability to use different gaits and hybridization probes to detect markers being associated with the ability to use different gaits and the ability to trot at a fast speed.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: August 13, 2019
    Assignee: CAPILET GENETICS AB
    Inventors: Lisa S. Andersson, Leif Andersson, Gabriella Lindgren
  • Publication number: 20180298604
    Abstract: A building element for a building includes a framework with at least one wooden beam and at least one facing sheet fixed to the beam of the framework. The building element also includes an insulating component made of mineral wool affixed to the beam in such a way as to cover the beam on the one hand on a frontal face and on the other hand on at least a part of the lateral faces. The insulating component affixed to the frontal face is interposed between the facing sheet and the beam.
    Type: Application
    Filed: April 28, 2016
    Publication date: October 18, 2018
    Applicant: SAINT-GOBAIN ISOVER
    Inventors: Carole DURANTET, Jan GOOR, Leif ANDERSSON
  • Publication number: 20180282812
    Abstract: The present invention relates to methods for detecting a genetic deletion at the SHOX locus of a horse, where the presence of such a genetic deletion indicates that the horse is a carrier of disease-causing mutation that can lead to skeletal atavism. The invention further provides nucleic acid primers and probes for use in methods for detecting the presence or absence of disease-causing genetic deletion at the SHOX locus of a horse.
    Type: Application
    Filed: June 11, 2018
    Publication date: October 4, 2018
    Applicants: University of Washington, Capilet Genetics AB
    Inventors: Sofia Mikko, Leif Andersson, Gabriella Lindgren, Carl-Johan Rubin, Bhanu Chowdhary, Terje Raudsepp, Evan E. Eichler, John Huddleston, Maika Malig
  • Publication number: 20170356047
    Abstract: The present invention provides methods for predicting the pattern of locomotion in a horse including the ability of a horse to use different gaits and the ability to trot at a fast speed. The methods comprise determining in a sample of DNA obtained from a horse the presence or absence of at least one genetic marker, wherein said at least one genetic marker is located on horse chromosome 23, said marker being associated with the ability to use different gaits. The invention further provides primers that amplify markers being associated with the ability to use different gaits and hybridization probes to detect markers being associated with the ability to use different gaits and the ability to trot at a fast speed.
    Type: Application
    Filed: August 21, 2017
    Publication date: December 14, 2017
    Applicant: Capilet Genetics AB
    Inventors: Lisa S. Andersson, Leif Andersson, Gabriella Lindgren
  • Publication number: 20160083796
    Abstract: The present invention relates to methods for detecting a genetic deletion at the SHOX locus of a horse, where the presence of such a genetic deletion indicates that the horse is a carrier of disease-causing mutation that can lead to skeletal atavism. The invention further provides nucleic acid primers and probes for use in methods for detecting the presence or absence of disease-causing genetic deletion at the SHOX locus of a horse.
    Type: Application
    Filed: May 5, 2014
    Publication date: March 24, 2016
    Applicants: Capilet Genetics AB, University of Washington
    Inventors: Sofia MIKKO, Leif ANDERSSON, Gabriella LINDGREN, Carl-Johan RUBIN, Bhanu CHOWDHARY, Terje RAUDSEPP, Evans E. EICHLER, John HUDDLESTON, Maika MALIG
  • Publication number: 20150376705
    Abstract: The present invention provides methods for predicting the pattern of locomotion in a horse including the ability of a horse to use different gaits and the ability to trot at a fast speed. The methods comprise determining in a sample of DNA obtained from a horse the presence or absence of at least one genetic marker, wherein said at least one genetic marker is located on horse chromosome 23, said marker being associated with the ability to use different gaits. The invention further provides primers that amplify markers being associated with the ability to use different gaits and hybridization probes to detect markers being associated with the ability to use different gaits and the ability to trot at a fast speed.
    Type: Application
    Filed: July 9, 2015
    Publication date: December 31, 2015
    Applicant: CAPILET GENETICS AB
    Inventors: Lisa S. Andersson, Leif Andersson, Gabriella Lindgren
  • Patent number: 9096901
    Abstract: This document relates to methods and materials for determining whether or not a horse contains a Grey allele. For example, diagnostic methods such as nucleic acid-based detection methods and materials such as nucleic acid probes and primer pairs that can be used to determine whether or not a horse contains a duplication in intron 6 of STX17 nucleic acid are provided. This document also relates to methods and materials for treating a mammal having or being likely to develop cancer (e.g., benign, malignant, or metastatic cancer). For example, methods and materials for treating cancer in a mammal by administering an agent having the ability to reduce expression of an STX17 polypeptide and/or an NR4A polypeptide (e.g., an NR4A1, NR4A2, or NR4A3 polypeptide) in the mammal are provided.
    Type: Grant
    Filed: September 4, 2012
    Date of Patent: August 4, 2015
    Assignee: Biocistronix AB
    Inventors: Leif Andersson, Gerli Rosengren Pielberg, Anna Olegovna Golovko, Kjell Robert Johan Lennartsson, Carl-Henrik Heldin
  • Publication number: 20150044681
    Abstract: The present invention provides methods for predicting the pattern of locomotion in a horse including the ability of a horse to use different gaits and the ability to trot at a fast speed. The methods comprise determining in a sample of DNA obtained from a horse the presence or absence of at least one genetic marker, wherein said at least one genetic marker is located on horse chromosome 23, said marker being associated with the ability to use different gaits. The invention further provides primers that amplify markers being associated with the ability to use different gaits and hybridization probes to detect markers being associated with the ability to use different gaits and the ability to trot at a fast speed.
    Type: Application
    Filed: August 25, 2014
    Publication date: February 12, 2015
    Applicant: CAPILET GENETICS AB
    Inventors: Lisa S. Andersson, Leif Andersson, Gabriella Lindgren
  • Publication number: 20140057253
    Abstract: The present invention provides methods for predicting the pattern of locomotion in a horse including the ability of a horse to use different gaits and the ability to trot at a fast speed. The methods comprise determining in a sample of DNA obtained from a horse the presence or absence of at least one genetic marker, wherein said at least one genetic marker is located on horse chromosome 23, said marker being associated with the ability to use different gaits. The invention further provides primers that amplify markers being associated with the ability to use different gaits and hybridization probes to detect markers being associated with the ability to use different gaits and the ability to trot at a fast speed.
    Type: Application
    Filed: May 4, 2012
    Publication date: February 27, 2014
    Applicant: CAPILET GENETICS AB
    Inventors: Lisa S. Andersson, Leif Andersson, Gabriella Lindgren
  • Publication number: 20130004520
    Abstract: This document relates to methods and materials for determining whether or not a horse contains a Grey allele. For example, diagnostic methods such as nucleic acid-based detection methods and materials such as nucleic acid probes and primer pairs that can be used to determine whether or not a horse contains a duplication in intron 6 of STX17 nucleic acid are provided. This document also relates to methods and materials for treating a mammal having or being likely to develop cancer (e.g., benign, malignant, or metastatic cancer). For example, methods and materials for treating cancer in a mammal by administering an agent having the ability to reduce expression of an STX17 polypeptide and/or an NR4A polypeptide (e.g., an NR4A1, NR4A2, or NR4A3 polypeptide) in the mammal are provided.
    Type: Application
    Filed: September 4, 2012
    Publication date: January 3, 2013
    Applicant: MELICA HB
    Inventors: Leif Andersson, Gerli Rosengren Pielberg, Anna Olegovna Golovko, Kjell Robert Johan Lennartsson, Carl-Henrik Heldin
  • Patent number: 8278043
    Abstract: This document relates to methods and materials for determining whether or not a horse contains a Grey allele. For example, diagnostic methods such as nucleic acid-based detection methods and materials such as nucleic acid probes and primer pairs that can be used to determine whether or not a horse contains a duplication in intron 6 of STX17 nucleic acid are provided. This document also relates to methods and materials for treating a mammal having or being likely to develop cancer (e.g., benign, malignant, or metastatic cancer). For example, methods and materials for treating cancer in a mammal by administering an agent having the ability to reduce expression of an STX17 polypeptide and/or an NR4A polypeptide (e.g., an NR4A1, NR4A2, or NR4A3 polypeptide) in the mammal are provided.
    Type: Grant
    Filed: June 5, 2008
    Date of Patent: October 2, 2012
    Assignee: Melica HB
    Inventors: Leif Andersson, Gerli Rosengren Pielberg, Anna Olegovna Golovko, Kjell Robert Johan Lennartsson, Carl-Henrik Heldin
  • Publication number: 20120100319
    Abstract: The invention concerns the insulation of a duct 2, especially an air-conditioning or ventilation duct, which passes through a penetration in a wall 1 or ceiling or the like, and an insulating material 3 is provided all around the outside of the duct 2. In this regard, the insulating material 3 has an end face pointing at least partly in the direction of the penetration. Sections of the end face, at least, are provided with heat-resistant adhesive material 11.
    Type: Application
    Filed: August 1, 2008
    Publication date: April 26, 2012
    Applicant: SAINT-GOBAIN ISOVER
    Inventors: Horst Keller, Andreas Köhler, Torsten Wahls, Leif Andersson, Hans-Jörg Frantz, Michael Schumm
  • Patent number: 7892736
    Abstract: The present invention relates to a method for selecting a domestic animal having desired genotypic properties comprising testing the animal for the presence of a parentally imprinted quantitative trait locus (QTL). The invention further relates to the use of an isolated and/or recombinant nucleic acid comprising a QTL or functional fragment derived therefrom to select a breeding animal or animal destined for slaughter having desired genotypic or potential phenotypic properties. In particular, the properties are related to muscle mass, fat deposition, sow prolificacy, and/or sow longevity.
    Type: Grant
    Filed: February 17, 2006
    Date of Patent: February 22, 2011
    Assignees: University of Liege, Melica HB, Seghers Gentec N.V.
    Inventors: Leif Andersson, Michel Georges, Geert Spincemaille, Carine D. A. Nezer
  • Patent number: 7858369
    Abstract: Transgenic non-human animals that express the ?3 subunit of PRKAG are described, as well as methods of using the transgenic non-human animals as models for improving treatment, prevention, or diagnosis of diseases related to energy metabolism, including obesity, dyslipidemia, insulin resistance syndrome, and type 2 diabetes.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: December 28, 2010
    Assignee: Arexis AB
    Inventors: Leif Andersson, Stefan Marklund
  • Publication number: 20100285462
    Abstract: This document relates to methods and materials for determining whether or not a horse contains a Grey allele. For example, diagnostic methods such as nucleic acid-based detection methods and materials such as nucleic acid probes and primer pairs that can be used to determine whether or not a horse contains a duplication in intron 6 of STX17 nucleic acid are provided. This document also relates to methods and materials for treating a mammal having or being likely to develop cancer (e.g., benign, malignant, or metastatic cancer). For example, methods and materials for treating cancer in a mammal by administering an agent having the ability to reduce expression of an STX17 polypeptide and/or an NR4A polypeptide (e.g., an NR4A1, NR4A2, or NR4A3 polypeptide) in the mammal are provided.
    Type: Application
    Filed: June 5, 2008
    Publication date: November 11, 2010
    Inventors: Leif Andersson, Gerli Rosengren Pielberg, Anna Olegovna Golovko, Kjell Robert Johan Lennartsson, Carl-Henrik Heldin
  • Publication number: 20100281547
    Abstract: Described are methods to select animals, such as mammals, particularly domestic animals, breeding animals or animals destined for slaughter, for having desired genotypic or potential phenotypic properties, in particular, related to muscle mass and/or fat deposition lean meat, lean back fat, sow prolificacy and/or sow longevity. Provided is a method for selecting an animal having desired genotypic or potential phenotypic properties comprising testing the animal, a parent of the animal or its progeny for the presence of a nucleic acid modification affecting the activity of an evolutionary conserved CpG island, located in intron 3 of an IGF2 gene and/or for the presence of a nucleic acid modification affecting binding of a nuclear factor to an IGF2 gene.
    Type: Application
    Filed: February 12, 2010
    Publication date: November 4, 2010
    Inventors: Leif Andersson, Goran Andersson, Michel Georges, Nadine Buys